NEJM questions sale of Meridia - "It is difficult to discern a credible rationale for keeping this medication on the market," they wrote.
Credits to Yahoo and AP
http://finance.yahoo.com/news/Journal-editors-question-sale-apf-905590735.html?x=0&.v=2
No comments:
Post a Comment